Impact of obstructive lung disease on survival in patients with rheumatoid arthritis related interstitial lung disease
Authors:
- Lee M. FidlerLFLee M. Fidler
- Omri A. ArbivOAOmri A. Arbiv
- Jolene H. FisherJFJolene H. Fisher
- Shane ShaperaSSShane Shapera
- Andrea S. GershonAGAndrea S. Gershon
- 30 July 2026
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 261
Abstract
No abstract availableFunding Information
- Ministry of Health, Ontario
- Canadian Pulmonary Fibrosis Foundation
- Ministry of Long-Term Care
This publication has 11 references indexed in Scilit:
- Hospitalization Trends and Risk Factors in Rheumatoid Arthritis-Related Interstitial Lung DiseaseChest, 2025
- Rheumatoid arthritis associated interstitial lung disease: Trends in epidemiology and mortality in Ontario from 2000 to 2018Respiratory Medicine, 2023
- Airway Disease in Rheumatoid ArthritisAnnals of the American Thoracic Society, 2022
- Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysisRespiratory Research, 2021
- Prevalence, incidence and cause-specific mortality of rheumatoid arthritis–associated interstitial lung disease among older rheumatoid arthritis patientsRheumatology, 2021
- Fifteen-year mortality of patients with asthma–COPD overlap syndromeEuropean Journal of Internal Medicine, 2016
- An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performanceBMC Musculoskeletal Disorders, 2014
- Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population studyThe Lancet, 2011
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2010
- Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndromeEuropean Respiratory Journal, 2009